Apex Biotechnology Corp.

Informe acción TWSE:1733

Capitalización de mercado: NT$3.3b

Apex Biotechnology Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Thomas Y. Shen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO10.4%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva6.4yrs

Actualizaciones recientes de la dirección

Recent updates

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Apr 17
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Mar 30
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Mar 10
Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

Feb 17
Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Jan 27
A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

Jan 06
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Dec 16
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Nov 22
Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

CEO

Thomas Y. Shen

no data

Permanencia

Dr. Thomas Y. S. Shen, Ph D serves as Chairman, Chief Executive Officer and General Manager of Apex Biotechnology Corp. Dr. Shen served as Supervisor/Corporate Representative at Sheng Da Venture Capital. D...

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Thomas Y. Shen
Chairmanno datasin datos10.38%
NT$ 347.5m
Meng Yang
Vice GMno datasin datossin datos
Yung-Luh Tsaih
Independent Director2.8yrssin datossin datos
I-Tan Chih
Independent Directorno datasin datossin datos
Pai Ming
Independent Director6.4yrssin datossin datos
Jin-Chang Bou
Independent Director6.4yrssin datossin datos

6.4yrs

Permanencia media

Junta con experiencia: La junta directiva de 1733 se considera experimentada (6.3 años de antigüedad promedio).